Cartesian Growth Corporat... (RENE)
11.83
-0.03 (-0.25%)
At close: Mar 26, 2025, 3:00 PM
Company Description
Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities.
The company was incorporated in 2021 and is based in New York, New York.
Cartesian Growth Corporation II
| Country | United States |
| IPO Date | Jul 8, 2022 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Dr. Peter Michael Yu Ph.D. |
Contact Details
Address: 505 Fifth Avenue New York, New York United States | |
| Website | https://www.cartesiangrowth.com/cgc2 |
Stock Details
| Ticker Symbol | RENE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001889112 |
| CUSIP Number | G19305112 |
| ISIN Number | KYG193051128 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Peter Michael Yu Ph.D. | Chairman & Chief Executive Officer |
| Beth S. Michelson CFA | Chief Financial Officer & Director |
| Gregory R. Armstrong | Senior Managing Director |
| Paul Seungpyo Hong Esq., J.D. | Senior Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 03, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 12, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 04, 2025 | 8-K | Current Report |
| Jan 02, 2025 | 8-K | Current Report |
| Dec 18, 2024 | 8-K | Current Report |
| Dec 04, 2024 | 8-K | Current Report |